Indivior PLC (LON:INDV - Get Free Report) shares crossed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 811.11 ($10.98) and traded as high as GBX 1,017 ($13.77). Indivior shares last traded at GBX 1,015 ($13.74), with a volume of 617,576 shares traded.
Indivior Stock Up 2.7%
The stock has a market capitalization of £1.59 billion, a P/E ratio of -841.58, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a debt-to-equity ratio of -170.06, a quick ratio of 1.52 and a current ratio of 0.83. The stock's fifty day simple moving average is GBX 811.11 and its two-hundred day simple moving average is GBX 840.11.
About Indivior
(
Get Free Report)
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Stories
Before you consider Indivior, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Indivior wasn't on the list.
While Indivior currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
